Mangoceuticals, Inc. (MGRX)

NASDAQ: MGRX · IEX Real-Time Price · USD
+0.05 (2.07%)
At close: Mar 24, 2023, 3:59 PM
+0.28 (11.34%)
After-hours: Mar 24, 2023, 7:58 PM EDT
Market Cap 37.83M
Revenue (ttm) n/a
Net Income (ttm) -17,701
Shares Out 15.32M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 232,888
Open 2.35
Previous Close 2.42
Day's Range 2.25 - 3.00
52-Week Range 2.25 - 4.37
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About MGRX

Mangoceuticals plans to connect consumers to licensed healthcare professionals through a recently launched website for the provision of care via telehealth on our customer portal and plan to also provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. To date, we have developed what we believe is a go-to-market strategy inclusive of product development, operations, marketing and advertising; however, we have not produced a sign... [Read more]

Sector Healthcare
IPO Date Mar 21, 2023
Employees 2
Stock Exchange NASDAQ
Ticker Symbol MGRX
Full Company Profile

Financial Performance

Financial Statements


Mangoceuticals, Inc. Announces Closing of $5 Million Initial Public Offering

DALLAS, TX / ACCESSWIRE / March 23, 2023 / Mangoceuticals, Inc. ("MangoRx" or the "Company") (NASDAQ:MGRX), a company focused on developing, marketing and selling a variety of men's health and wellnes...

3 days ago - Accesswire

Mangoceuticals, Inc. Announces Pricing of Initial Public Offering

IPO Shares to Commence Trading Today on Nasdaq under Ticker Symbol "MGRX" DALLAS, TX / ACCESSWIRE / March 21, 2023 / Mangoceuticals, Inc. ("MangoRx" or the "Company")(NASDAQ:MGRX), a company focused o...

5 days ago - Accesswire

Men's wellness products provider Mangoceuticals files and sets terms for a $5 million IPO

Mangoceuticals, which provides an erectile dysfunction product via telehealth, filed on Friday with the SEC to raise up to $5 million in an initial public offering.

2 months ago - Renaissance Capital

Mangoceuticals IPO Registration Document (S-1)

Mangoceuticals has filed to go public with an IPO on the {Market}.

2 months ago - SEC